Search company, investor...

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Series A | Alive

About Jianyi

Operator of a third party medical insurance platform. The company provides third party medical insurance claims payment processing services. It also cooperates with healthcare institutions to offer healthcare insurance products and healthcare management services.

Jianyi Headquarters Location

1687 Changyang Road 4th Floor

Shanghai, Shanghai, 200020,


86 21 62563889

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Jianyi News

Researchers receive $11.2M to study how the heart recovers from significant damage The National Heart, Lung and Blood Institute,...

Aug 23, 2022

Jianyi "Jay" Zhang, MD, PhD, is leading one of three major NIH-funded research projects on growing new heart muscle cells. Photo courtesy of The University of Alabama at Birmingham. The National Heart, Lung, and Blood Institute —part of the National Institutes of Health —has awarded an $11.2 million grant to researchers who will investigate, among other things, the possibility of restoring dead heart tissue after a myocardial infarction. The grant will fund three related projects that each build on a recent discovery by Jianyi “Jay” Zheng, MD, PhD , and colleagues, that neonatal pigs can remuscularize dead heart tissue through cardiomyocyte proliferation. Normally, dead tissue will eventually be replaced by scar tissue, which can strain remaining heart muscle and may eventually contribute to heart failure . “Recent preliminary studies from our laboratories using neonatal pigs have shown that, when a myocardial infarction is induced on postnatal day 1, or P1, cardiomyocytes reenter the cell cycle, proliferate and completely restore cardiac function with little scarring,” Zhang, chair of the University of Alabama at Birmingham ’s Department of Biomedical Engineering , said in a statement . Zhang will lead the first project, which aims to identify cardiomyocyte cell-cycle regulators and learn how to target them in a way that will cause cardiomyocytes to re-enter the cell cycle and proliferate. Additionally, researchers will use stem cells to generate novel “muscle patches” with activated cell-cycle regulators and layers of other cardiac cells. Then—using what they discover about targeting regulators as well as the muscle patches—the researchers will attempt to remuscularize adult pigs’ hearts after a heart attack. “The findings from the large-mammal cardiac muscle regeneration will have unprecedented clinically relevant dimensions,” the statement notes. In the second NIH-funded project, Daniel J. Garry, MD, PhD , of the University of Minnesota Medical School , will lead researchers in investigating whether they can promote cardiomyocyte proliferation in adult mice and pigs by using certain effectors of the Sonic Hedgehog developmental pathway. In the third project, Hesham Sadek, MD, PhD , of the University of Texas Southwestern Medical Center , “looks at the intriguing hypothesis that selective utilization of proline metabolism promotes the survival of heart ventricular myocytes and proliferation under conditions of low oxygen.” Related Content:

  • Where is Jianyi's headquarters?

    Jianyi's headquarters is located at 1687 Changyang Road, Shanghai.

  • What is Jianyi's latest funding round?

    Jianyi's latest funding round is Series A.

  • Who are the investors of Jianyi?

    Investors of Jianyi include Share Capital.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.